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Rationale: Exogenous cortisol is a modulator of behavior related to increased motivated
decision making (Putman et al., 2010), where risky choices yield potentially big reward.
Making risk based judgments has been shown to be important to athletes in optimizing
pacing during endurance events (Renfree et al., 2014; Micklewright et al., 2015).
Objectives: Therefore, the aims of this study were to examine the effect of 50mg
exogenous cortisol on neurophysiological responses and risk taking behavior in nine
healthy men. Further to this, to examine the effect of exogenous cortisol on exercise
performance.
Methods: Using a double blind counterbalanced design, cyclists completed a placebo
(PLA), and a cortisol (COR) trial (50mg cortisol), with drug ingestion at 0min. Each trial
consisted of a rest period from 0 to 60 min, followed by a risk taking behavior task, a
30min time trial (TT) with 5 × 30 s sprints at the following time intervals; 5, 11, 17, 23,
and 29min. Salivary cortisol (SaCOR), Electroencephalography (EEG) and Near Infrared
Spectroscopy (NIRs) were measured at 15, 30, 45, and 60min post-ingestion. Glucose
and lactate samples were taken at 0 and 60 min post-ingestion. During exercise, power
output (PO), heart rate (HR), EEG, and NIRS were measured. SaCOR was measured 10
min post-exercise.
Results: Cortisol increased risk taking behavior from baseline testing. This was in
line with significant neurophysiological changes at rest and during exercise. At rest,
SaCOR levels were higher (P < 0.01) in COR compared to PLA (29.7 ± 22.7 and
3.27 ± 0.7 nmol/l, respectively). At 60 min alpha slow EEG response was higher in
COR than PLA in the PFC (5.5 ± 6.4 vs. −0.02 ± 8.7% change; P < 0.01). During
the TT there was no difference in total km, average power or average sprint power,
although Peak power (PP) achieved was lower in COR than PLA (465.3 ± 83.4 and
499.8 ± 104.3; P < 0.05) and cerebral oxygenation was lower in COR (P < 0.05).
Robertson et al. Exogenous Cortisol and Risk Taking Behavior
Conclusion: This is the first study to examine the effect of exogenous cortisol on
exercise performance. These results are in line with previous research showing altered
risk taking behavior following exogenous cortisol, however the altered behavior did not
translate into changes in exercise performance.
Keywords: risk taking, exogenous cortisol, neurophysiological responses, BART test, exercise performance
INTRODUCTION
Cortisol is generally associated withmediating the primary effects
of stress such as aversive and avoidance inducing behavior
(Marinelli and Piazza, 2002) and is widely used as a biomarker
for stress (Hellhammer et al., 2009). Conversely, the provision of
exogenous cortisol has recently been shown to be a modulator
in processing of threat related stimuli, such as reduced fearful
symptomology in those with post-traumatic stress disorder
(PTSD; Putman et al., 2007). Exogenous cortisol has also
been shown to increase motivated decision making behavior in
humans (Putman et al., 2010). Further to this, animal models
have shown that high levels of glucocorticoids (GCs) increase
reward and approach related behavior (Piazza et al., 1996a;
Marinelli et al., 1998; Mikics et al., 2007), produce greater
locomotor activity and higher levels of impulsivity (Koob and
Bloom, 1988; Piazza et al., 1991, 1996b). The mechanisms by
which exogenous cortisol may alter reward and approach related
behavior has been postulated to be due to increased dopamine
(DA) activity (Marinelli and Piazza, 2002) which occurs when
stress levels of GCs induce an increased release of DA from the
nucleus accumbens (Rougé-Pont et al., 1998), a component of the
brain’s reward system (Roitman et al., 2005).
Within an athletic situation, making risk based judgments has
been proposed to be important to athletes in optimizing pacing
during endurance events (Micklewright et al., 2015). Not only is
it important to ensure that pacing is optimized but, in achieving
the fastest overall speed possible, pace at the end of the event is
not compromised resulting in a slower overall time. In addition
to this, during a race or event, competitors are subject to further
risk evaluation situations (Renfree et al., 2014; Micklewright
et al., 2015). Exposure to external environmental conditions may
alter the decisions and calculations that are being made by the
brain in relation to pacing. The presence of opponents and the
necessity to respond to them, creates the need to weigh up all
possible behavioral choices, relating to a change in pace, and their
associated benefits and risks (Renfree et al., 2012, 2014).
An individual’s propensity to take risks and its effect on
performance, pacing and RPE, has recently been examined
(Micklewright et al., 2015). Cyclists with a higher perception of
risk showed a slower starting pace and perception of risk was
also shown to be associated with deviations from a predicted
pace (Micklewright et al., 2015). Ultra-marathon runners were
also investigated revealing the same relationship with greater risk
perception, associated with slower starting pace (Micklewright
et al., 2015). Whilst risk played a role in pacing strategy,
their overall race time in both events examined was the same.
Calculation of a hazard score has also shown that a fast
start elevates the perception of hazard compared to a slow
start (Williams et al., 2015) but again with no change in TT
performance. These data show that a greater perception of risk
results in slower starting strategies which is likely due to the risk
assessment of having to get to the end of the race with less chance
of a catastrophic collapse (de Koning et al., 2011). As of yet the
internal manipulation of risk behavior via exogenous cortisol and
the impact on exercise performance has yet to be examined.
Therefore, the aims of this study were to examine the
effect of exogenous cortisol on neurophysiological responses and
risk taking behavior. Further to this, to examine the effect of
exogenous cortisol on time trial performance. The hypothesis
was that risk taking behavior would be enhanced with exogenous
cortisol and that this would also influence participants approach
to exercise, with a less risk adverse approach.
EXPERIMENTAL PROCEDURES
Subjects and Ethical Approval
Eleven, healthy, trained, male cyclists from local cycling and
triathlon clubs were recruited for this study. Participants were
required to have been training for at least 2 years and to
be currently training for a minimum of 2 h a week. Each
participant was paid a small amount on completion of the
study, as an incentive to participate. Their mean ± SD age,
height, weight, V˙O2 max and maximal aerobic peak power
were, respectively; 39.6 ± 10.4 years, 183.7 ± 8.2 cm, 83.6
± 14.0 kg, 4.4 ± 0.6 l min−1, 397.1 ± 36.3 W. After being
informed of the risks associated with the experiment each
participant signed a letter of informed consent. Subjects were
cleared by a physician for any contraindications of consuming
50mg of cortisol as defined by the medical practitioner; which
included neurological diseases as well as dysfunction of the
adrenal glands. The study was approved by the Charles Sturt
University Research and Ethics Committee and conformed
to standards set by the latest revision of the Declaration of
Helsinki.
Procedure
Participants attended the laboratory on three different occasions;
baseline and two intervention trial visits. At each intervention
trial, participants were given either 50mg of cortisol (COR)
or a placebo (PLA). The experimental design was double
blinded, randomized and counterbalanced. All test sessions were
scheduled to take place between 1300 and 2000 h to reduce
diurnal variations of the cortisol response (Putman et al.,
2010) and at a time when hormone levels are relatively stable
(Henckens et al., 2012). Each participant was tested at the
same time of day for all visits. Prior to each visit subjects
were asked to refrain from any exercise for at least 24 h prior
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to testing and to undertake only easy training from 36 h
prior to each visit. All participants maintained a regular diet
during the study period and were asked to refrain from alcohol
ingestion for at least 24 h prior to testing and caffeine 6 h prior.
Participants were required to not consume any food or drink
with the exception of water from 1.5 h prior to arriving at the
laboratory. Prior to each visit subjects were provided with a
food diary to complete which ensured that meals were consumed
at the same time of day to avoid interaction with diurnal
changes in cortisol and food intake (Follenius et al., 1982). This
also served to ensure that macronutrient intake was kept the
same to maintain high levels of muscle glycogen for exercise
performance.
BASELINE AND INITIAL SCREENING
As part of an initial screening process, participants collected
salivary cortisol measures on the morning of their baseline
test to determine cortisol awakening response (CAR). Samples
were collected on awakening, and at 30, 45, and 60 min
post-wakening. Samples were collected by placing oral swabs
under the front of the tongue for 2 min before being placed
into salivette tubes (Salimetrics, State College, PA, USA) and
refrigerated. Participants were instructed to only drink water
during this period and for nothing to be consumed 10 min
prior to each sample. These instructions were explained verbally
as well as via written instructions provided with the salivettes
and swabs. After collection samples were frozen at −20◦C until
analysis.
This was completed to ensure that participants did not
have dysfunctional cortisol regulation. On the afternoon of
the same day, participants came into the lab to complete
a baseline (BASE) visit including an initial Balloon Analog
Risk Task (BART) described subsequently (Lejuez et al.,
2002), and a maximal oxygen uptake test to establish fitness
levels.
Balloon Analog Risk Task (BART)
Reliability of the BART test has been shown previously both
within (Lejuez et al., 2002) and across (Lejuez et al., 2003a) task
administrations. The test has also been validated for risk taking
behavior in adolescents (Lejuez et al., 2003b) and risk taking
behaviors such as drug use (Lejuez et al., 2004) and delinquent
activity (Aklin et al., 2005). Participants completed the computer
based test and were blinded to the rationale behind the test so that
they could not manipulate the results.
The computer screen showed a small simulated balloon
accompanied by a balloon pump, a button labeled Collect
$$$, as well as a “money earned” display which informed
the participants of the running total of money earned to
that point. Participants were blinded from the amount earned
per balloon. This was to ensure that they could not judge
how many times they had pumped up the balloon. Each
participant was faced with 30 balloons which were set to
explode randomly. When each balloon was pumped past its
set point, it exploded and no money was accrued and a
new balloon was presented. If the Collect $$$ button was
pressed before the balloon exploded, the participants earned
the money from the number of pumps on completed on that
balloon. At any point during each balloon trial, the participant
could stop pumping the balloon and click the “collect $$$”
button.
Exercise Tests
Maximal Oxygen Uptake
Participants were fitted with a facemask (Hans Rudolph Kansas
City, MO) connected to a rapid response gas analyser (AEI
Technologies, Pittsburgh, PA, USA) for the measurement of
pulmonary gas exchange. A 1min resting sample was collected
before the initiation of the test. Cyclists performed a cycle ramp
test to exhaustion on a Lode cycle ergometer consisting of a
ramp increase in power output of 30W min−1 (1 W every 2 s)
until volitional exhaustion. Participants were asked to maintain
their preferred cadence (all participants selected between 80
and 100 rpm) for as long as possible. The test was terminated
voluntarily by each subject when they could no longer sustain the
required power output whilst staying seated in the saddle. The
test was performed in a quiet room with no internal or external
interruptions and no verbal encouragement was provided during
the test.
Pulmonary gas exchange was measured breath-by-breath
throughout the exercise test using a custom-designed expired
gas analysis metabolic system. All data were acquired using
custom-developed software (LabVIEW; National Instruments,
Austin, TX, USA) and commercial electronic acquisition devices
(National Instruments).
Thirty Minute Cycle Test Familiarization
Following a rest period of at least 15 min participants were then
required to complete 15min of the 30min protocol to ensure that
they were familiar with the bike gearing and the requirement for
sprinting during an all-out time trial type effort.
INTERVENTION TRIALS
Each participant also completed two intervention visits, in
addition to the BASE visit, as described subsequently. All test days
were completed within 15 days with at least 2 days between trials.
Resting Measurements
On arrival at the laboratory subjects were seated and made
comfortable. They were instructed that they were allowed to
drink water during the resting period as long as they did
not drink within 10 min of a saliva sample. Following this
they were fitted with a wireless EEG headset (B-Alert, ABM,
Ca) and two near-infrared spectrometer (NIRs) probes (NIRO-
200, Hamamatsu, Japan), outlined subsequently. EEG and NIRs
measures were taken at rest. Subjects also provided a resting
saliva sample, as described above. Capillary blood samples were
provided for the determination of blood lactate and glucose as
described subsequently. Following initial resting measures (at
0min), subjects were given two capsules to take, containing either
50mg cortisol (COR; Cortate, Aspen Pharmacare, NSW, Aus)
or placebo (PLA). This dose was chosen as it is the equivalent
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to the highest dose given to humans in a research environment
(van Peer et al., 2008). The EEG, NIRS, and salivary resting
measures were repeated at the following time points post-capsule
ingestion; 15, 30, 45, and 60 min. A second blood sample was also
taken at 60 min post-ingestion. Following this, the participants
were asked to complete a BART test, as described above (see
Figure 1).
Exercise Trials
Following completion of the BART test, subjects were transferred
to the cycle ergometer (Racermate, Velotron, WA, USA) and
provided with a standardized 5 min 100 W warm up before
beginning the trial. Bike set up was replicated as per their
BASE trial. Each exercise trial consisted of a 30min effort
with 30 s sprints at the following time intervals; 5, 11, 17,
23, and 29 min. Sprints were included in the protocol to
allow potential access to higher levels of work regulation
which might appear with the cortisol ingestion. During the
30 min trial, participants were blinded to all feedback with
the exception of time. This ensured that they were unaware
of their performance level between trials, but that the exercise
bout was closed loop allowing self-pacing. Each participant
was asked to approach the exercise bout as they would a
race and to complete as much distance as possible in the
30min.
During exercise, power output (W), distance (km), and heart
rate were recorded continuously. EEG and NIRS samples were
collected for 30 s, 1min prior to each sprint at the following
steady state (ss) time points; 4, 10, 16, 22, and 28min. During
this collection period, participants were asked to keep their
eyes closed to reduce eye blink noise and to maintain as
stable a cycling posture as possible in order to avoid excess
movement artifact. During each 30 s sprint NIRS data were
collected. No EEG data were collected at this time due to
the noise associated with collecting EEG during high intensity
exercise. Following each sprint an RPE score was obtained.
Exercise blood samples were collected via finger prick capillary
technique at 14 min (BL 1) and 26 min (BL 2); which equated
to approximately half way through the protocol and as near
to the end as possible without interfering with the other
measurements taking place. Immediately post-exercise, subjects
were permitted to have one drink of water if they wished and 10
min post-exercise a further salivary cortisol sample was taken (see
Figure 1).
MEASUREMENTS
Heart Rate
Heart rate in beats.min−1 (HR) was measured and recorded
with a chest strap and monitor (Polar RS400, Kempele, Finland)
continuously throughout the trials.
Rating of Perceived Exertion (RPE)
As an index of perceived exertion, the RPE was assessed using
the Borg scale (Borg, 1990) where rankings ranged from 6 (no
exertion at all) to 20 (maximal exertion). RPE ratings were taken
at the end of each sprint and denoted as the following time points;
RPE 1, 2, 3, 4, and 5.
Blood Collection and Biochemical Analysis
For each resting and exercise blood draw a 100µL sample
of capillary blood was collected from a hyperemic fingertip
for analysis of blood lactate and glucose (ABL825 Radiometer,
Copenhagen, Denmark).
Neurophysiological Measurements
Electroencephalography (EEG)
Subjects were fitted with a 20 channel, 256Hz, wireless
electroencephalography (EEG) headset (B-Alert, ABM, Ca).
Measurements for EEG strap size were taken; Sagittal, coronal
plane, and circumferential measures were taken for correct
strip size and EEG placement using the 10–20 international
system (Rowan and Tolunsky, 2006). Marker pen was used
for placement of marks on the forehead at 10% of the
coronal measure from the nasion to the inion for placement
of FP1 and FP2, to ensure correct strip placement as defined
by Jasper (cited in Rowan and Tolunsky, 2006). Synapse
Conductive Electrode Cream (ABM, Ca) was used to increase
conductance from scalp to electrode. The impedance of all
electrodes was maintained below 40 k as suggested by the
manufacturer due to the hybrid active electrodes. Paired mastoid
references were used and electrode and reference sites were
cleaned and abraded prior to fitting. Data were sampled with
a bandpass filter from 0.5 to 65Hz (at 3 dB attenuation)
obtained digitally with Sigma-Delta A/D converters. Data were
acquired wirelessly across a RF link via an RS232 interface. The
EEG signals were inspected continuously via online assessment
at rest and during exercise. While EEG was recorded at
all 20 electrode sites, data produced at the following sites
were used for analysis; F3, F4, Fz, F7, F8, FP1, FP2, C3,
C4, Cz.
Near-Infrared Spectroscopy (NIRS)
Two near-infrared spectrometer (NIRS) probes (NIRO-200,
Hamamatsu, Japan) were placed over the left and right pre
frontal lobes between FP1 and F3 (left) and FP2 and F4 (right;
Billaut et al., 2010). The NIRS probes were adhered to the skin
after the EEG strip had been put in place in accordance of
the 10–20 international system to ensure accurate placement
for each repeat trial. Each probe pair was placed in a black
plastic probe holder, with predefined inter optode spacing of
4 cm. The larger inter optode distance was chosen to provide
a greater maximum depth measured (Okada et al., 1995). The
emission and detection probes were placed in opposite directions
for each channel and the detection probes placed next to each
other when on the forehead. The probes were housed in black
rubber holders and attached to the skin with double sided
adhesive discs. The probe holders were also secured in place by
a black headband to reduce any extraneous light infiltration and
to prevent any change in their position during exercise. Data
were sampled at 1Hz. Resting measurements of both EEG and
NIRS were taken for 1min with eyes closed (EC). This served
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FIGURE 1 | Schematic representation of the intervention trials with resting and exercise measures at their relevant time points. Physiological measures
at rest; EEG and NIRS, salivary cortisol (Sa), blood glucose (gluc), and blood lactate (La). Balloon Analog Risk Task (BART) completed following all resting measures.
Measures during exercise at steady state (SS) time points; NIRs, EEG. Measures during each sprint (S); NIRs. Blood samples (glucose and lactate) taken at two time
points throughout, BL1 and BL2. Salivary cortisol (Sa) taken at 10min post-exercise.
to provide a baseline of 60 s to which other data points were
normalized.
Data Analysis
Ventilatory Parameters
Breath-by-breath gas exchange data from all V˙O2 max tests
were transferred to a spreadsheet program (Microsoft Excel) for
further analysis. All V˙O2 data were time averaged over eight
breaths. V˙O2max was determined by the highest serial average of
eight breaths as has been performed previously (Robertson and
Marino, 2015).
Power Output and Distance
Power output and distance were downloaded from the computer
files generated by the cycle ergometer (Racermate, Velotron,WA,
USA). Power output was averaged over the whole 30m min
trial, as well as the for each steady state period. Peak power
and average power output were obtained for the sprints. Total
distance completed was obtained from each file.
EEG Analysis
EEG data were processed and analyzed using B-Alert lab (Version
2.0, ABM, Ca). Each 30 s sample was visually inspected for
artifact (Polyman, version 1.153.1065) and eye blink and muscle
artifact was removed by the B-Alert decontamination algorithms.
Decontaminated data were then Fast Fourier Transformed into
power spectra and power spectral densities were calculated
for the following frequency bands; Alpha slow (αS) (8–10
Hz), alpha fast, (αF) (10–13Hz), Beta (β) (13–30Hz), and
Gamma (30–40Hz). Prior to statistical analysis EEG channels
were divided into specific regions based on Brodmann’s areas
(Brodmann, 2006) aligning with 10–20 international EEG system
as follows; Ventrolateral prefrontal cortex (VLPFC) F7 and F8,
Dorsolateral prefrontal cortex (DLPFC) F3 and F4, Anterior
prefrontal cortex (AntPFC) FP1 and FP2 and motor cortex
(MC) C3, CZ, and C4. Both resting and exercise data were then
calculated as percent changes from EC power spectral density
baseline measures to correct for day-to-day and between-subject
variability as previously reported (Nielsen et al., 2001; Bailey
et al., 2008).
NIRS Analysis
Changes in concentration of Oxyhemoglobin (OHb) and De-
Oxyhemoglobin (HHb) were calculated using the modified Beer-
Lambert law, based on changes in light attenuation at three
wavelengths and the adult forehead differential path length factor
of 5.93 (Van der Zee et al., 1992). Tissue Oxygenation Index
(TOI) and normalized Tissue Hemoglobin Index (nTHI) were
measured by the Spatially Resolved Spectroscopy (SRS) method.
The TOI is a percentage ratio ofOHb to Total Hemoglobin (THb)
and represents the oxygen saturation of tissue hemoglobin. The
nTHI is the sum of OHb and HHb, expressed as a ratio, which
represents the relative concentration of total tissue hemoglobin
and is, therefore, an indicative measure of regional blood volume
(Van Beekvelt et al., 2001). Following testing, data were imported
into an excel spreadsheet for normalization to the baseline
measure. Each parameter was averaged for the period of the data
collection (60 s during rest, 30 s during exercise). These averaged
data were then normalized as percentage change from baseline.
Salivary Cortisol Analysis
Salivary cortisol concentrations were determined using
commercially available high sensitivity enzyme immunoassay
(ELISA) kits (Salimetrics, State College, PA, USA). Samples were
defrosted, vortexed, and centrifuged prior to starting the analysis
process. The intra-assay coefficient of variation for the duplicate
samples was 7.8% across five plates and 190 samples run in
duplicate.
Statistical Analysis
Due to injury, one participant had be excluded from the exercise
sessions, therefore, the data are reported as n = 10, unless
otherwise stated. All data were tested for normal distribution
using a Shapiro-Wilks test. Data were analyzed using three and
two way General Linear Model Repeated Measures ANOVAs.
Resting and exercise NIRS and EEG data were analyzed
initially using a three way ANOVA for drug × hemisphere ×
time. Resting EEG were analyzed dependent on the channels in
question. For the PFC, the channels were divided into regions
(ANTPFC, DLPFC, VLPFC) and run as a three way ANOVA for
drug × region × time. In the instance of exercise EEG all data
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were analyzed as a two way ANOVA for drug × time, due to
removal of some subject’s data, meaning that it was not possible
to compare regions with each other without losing statistical
power. Following a significant F-test, pair-wise differences were
identified using a Bonferoni post-hoc test. One way ANOVAs
with Tukey’s correction for multiple comparisons post-hoc test
was used to locate differences when a significant main effect or
interaction effect was identified. Significance was set at P < 0.05.
Results are presented as means± SD.
RESULTS
Cortisol Awakening Response
Salivary cortisol levels (nmol/l) significantly increased from
awakening (0) to 30min (13.3 ± 5.04 and 29.04 ± 9.5,
respectively; P< 0.01).When represented as area under the curve
relative to ground (AUCG), cortisol response was significantly
increased at all time points with T30 being significantly higher
than T45 and T60 (852.9 ± 211.3, 624.1 ± 192.7, and 504.5 ±
265.0, respectively; P < 0.05).
Resting Measurements
Salivary Cortisol Responses
Peak salivary cortisol values were significantly higher (P= 0.001)
in COR than PLA (33.8± 21.3 and 4.2± 1.7 nmol/l, respectively;
see Figure 2). There was also a significant effect of time (P <
0.001) and a drug × time interaction (P < 0.001). Post-hoc
analysis revealed COR to be higher than PLA at 45 and 60 (20.4
± 20.3 vs. 3.3± 1.2, 29.8± 22.8 vs. 3.3± 0.7 nmol/l, respectively;
P< 0.05 and P< 0.01, respectively). Salivary cortisol in the COR
trial significantly increased over time with both 45 and 60 being
higher than 0 (45 and 60 min vs. 0; P < 0.05), 15 (45 and 60 min
vs. 15; P < 0.05), and 30 (45 and 60 min vs. 30; P < 0.01). Values
in the PLA condition actually decreased over time with 30 min
being significantly lower than 0 (P < 0.01).
Neurophysiological Measures
Electroencephalography
Prefrontal cortex
There was a significant effect of the drug on the bandwidth
response in the ANTPFC and the VLPFC (P< 0.05) for the COR
to be higher than the PLA trial, but not the DLPFC.
Bandwidth Response: Alpha Slow (αS)
Anterior prefrontal cortex
Within the ANTPFC, αS was significantly higher, on average, in
the COR trial compared to PLA (3.67 ± 5.28 vs. 1.0 ± 5.79%,
respectively, P< 0.05; see Figure 3A).
Ventrolateral prefrontal cortex
Within the VLPFC αS was significantly higher, on average,
in the COR trial compared to PLA (2.96 ± 5.13 vs.
−0.13 ± 5.82%, respectively; P < 0.05; see Figure 3B).
There was also a trend for a significant drug × time
interaction (P = 0.067). Post-hoc analysis revealed significant
increases from 15 and 30 to 60 min post-ingestion
(P < 0.05).
FIGURE 2 | Salivary cortisol responses at rest and 10 min
post-exercise. Values were significantly higher in COR (•) than PLA (o) at the
same time point, at 45 (*P < 0.05), 60 and post-exercise (**P < 0.01). Salivary
cortisol levels significantly increased across the COR trial, being higher at 45,
60, and post-exercise compared to 0 (aP < 0.05), 15 (bP < 0.05), and 30 (cP
< 0.01). PLA increased significantly at post-exercise (#P < 0.01) compared to
all other time points in the PLA condition. Post-exercise PLA values were also
higher than COR at 0 and 15min (δP < 0.01). PLA decreased from 0 to 30 min
(+P < 0.01).
Bandwidth Response: Gamma (γ)
Anterior prefrontal cortex
There was a trend for a significant drug × time interaction (P =
0.06) with the bandwidth γ. Post-hoc analysis found no significant
differences between the two drug conditions (Figure 4A).
Ventrolateral prefrontal cortex
There was a significant drug × time interaction (P < 0.05).
Post-hoc analysis found a significant (P < 0.05) change
across time with COR 60min (2.4 ± 16.6%) being lower
than 15 (8.9 ± 16.8%), and higher than 30 (−0.2 ±
15.5%) but with no significant changes to the PLA trial
(Figure 4B).
Motor Cortex
Bandwidth response: alpha slow (αS)
There was a trend for a significant drug × time interaction (P
<0.067). Post-hoc analysis showed a significant increase from
30 to 45min (0.6 ± 6.1 vs. 3.3 ± 5.8%) in the COR trial (P <
0.05; see Figure 3C) but with no significant changes in the PLA
trial.
Bandwidth response: gamma (γ)
There was a trend for a significant drug × time interaction (P
= 0.06). There was also a trend for percentage change at COR
60 (3.88 ± 5.1%) to be higher than COR 15 (0.14 ± 6.2%; P =
0.07; see Figure 4C) but with no significant changes in the PLA
trial.
There were no significant differences across the resting period
in αF or β responses.
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FIGURE 3 | EEG Alpha slow (αs) bandwidth responses to COR (•) and
PLA (o) in ANTPFC (A), VLPFC (B), and MC (C) during rest presented as %
change from rest (0 min) to 15, 30, 45, and 60 min post-ingestion. (A): The
COR trial was significantly higher in the ANTPFC (*P < 0.05) compared to
PLA. (B): αS increased across time with 60 min being significantly higher than
both 15 and 30 min (*P < 0.05). (C): In the MC αS increased in the COR trial
from 30 to 45 min (*P < 0.05).
FIGURE 4 | EEG Gamma bandwidth responses to COR (•) and PLA (o)
in ANTPFC (A) , VLPFC (B), and MC (C) during rest. Presented as % change
from rest (0 min) to 15, 30, 45, and 60 min post-ingestion. There was a trend
for percentage change at COR 60 (3.88 ± 5.1%) to be higher than COR 15
(0.14 ± 6.2%) (#P = 0.07).
Hemispherical Differences
There were no hemispherical differences between COR and PLA
suggesting that changes to neurophysiological measures were
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global or regional rather than the drug effecting one hemisphere
of the brain differently than the other.
Near Infrared Spectroscopy
There were no significant differences in NIRS responses in any of
the four parameters measured; OHb, HHb, nTHI, and TOI. There
was a trend (P = 0.07) for an effect of drug in HHb suggesting
COR may result in HHb compared to PLA.
Blood Measures
There were no significant differences between baseline measures
and 60min post-ingestion in blood glucose responses in either
COR or PLA (see Table 1). Blood glucose values were also
assessed for change across time within individuals, but these were
not significant. From resting (0min) to 60min post-ingestion,
change in blood glucose in the COR and PLA trial was −0.2 ±
0.9 and−0.1± 0.4 nmol/l, respectively.
The Effect of Cortisol Ingestion on BART
Test Performance
One way ANOVAs with Dunnett’s multiple comparisons test was
used to test differences between the BASE and the COR and PLA
in the following parameters of the BART test; Pumps adjusted
average, Explosions (total), pumps adjusted average (pumps
21–30), pumps adjusted total and total pumps (not adjusted
for explosions). One subject was removed due to improper
completion of the test.
Two significant differences were found. Pumps adjusted
average for COR was significantly higher (P < 0.05) compared
to the BASE trial (1313.5 ± 162.9 vs. 1149 ± 192.5) but not
PLA (1239 ± 183.7). Total pumps altogether (not adjusted for
explosions) was also significantly higher in COR than the BASE
trial (48.2± 6.2 vs. 40.6± 8.1; P < 0.01; see Figure 5).
No other differences were found between the BASE trial and
either COR nor PLA.
Exercise Data
Exercise Performance
All average performance data are shown in Table 2. There were
no significant differences between distance covered, total average
TABLE 1 | Plasma lactate and glucose responses during rest and exercise
in mmol.L−1 as mean ± SD following ingestion of cortisol (COR) or
placebo (PLA).
Blood lactate Blood glucose
(mmol/L) (mmol/L)
COR PLA COR PLA
Baseline 1.48 ± 0.45 2.01 ± 1.36 5.5 ± 0.44 5.5 ± 0.44
60 min
post-ingestion
1.67 ± 0.76 2.66 ± 0.54 5.4 ± 0.36 5.4 ± 0.36
BL 1 9.3 ± 2.6* 9.8 ± 4.6* 5.9 ± 1.36 6.46 ± 0.8
BL 2 9.8 ± 4.2* 9.9 ± 4.6* 6.7 ± 1.05& 7.1 ± 1.2&
Significant effect of time with exercise lactate levels being significantly (*P < 0.01) higher
than both baseline and 60min post-ingestion. Blood glucose responses were significantly
higher at exercise 2 compared to 60min post-ingestion (&P <0.01).
power output, average sprint and average steady state power
output between trials. During steady state, PO decreased from
SS2 to SS4 and SS5 (∗P < 0.05) but with no difference between
trials (see Figure 6). Peak power obtained during each trial was
significantly lower (P< 0.05) in COR compared to PLA (461.4±
87.8 and 499.8± 104.3 W), respectively (Table 2).
Rating of Perceived Exertion (RPE)
Mean RPE was not significantly different between COR (16.7 ±
1.98) and PLA (16.9± 1.89). There was a significant effect of time
(P < 0.001), with RPE at each time point being higher than RPE
1. There was also an increase between RPE 2 and RPE 3 (P< 0.05)
and RPE 2 and RPE 5 (P < 0.05).
Blood Markers
There was a main effect of time (P < 0.01) with blood lactate
being higher during exercise at both time points compared to
both resting samples (see Table 1). Blood glucose responses were
significantly higher at BL 2 compared to 60 min post-ingestion
(P < 0.01; see Table 1). There were no differences between
conditions in either measure.
Heart Rate
Heart rate (HR) significantly increased during exercise in both
steady state and sprint periods (P < 0.001). There was no
difference between trials. HR in the steady state (SS) periods
increased in the COR and PLA trials from 144.8 ± 17.1 to 175.1
± 13.3 and from 141.9 ± 16.6 to 175.1 ± 14.7. During the
(SS) periods each value was significantly (P < 0.05) higher than
the previous one except between points 4 and 5. During the
sprints average HR also increased significantly for consecutive
time points.
Neurophysiological Measurements
Electroencephalography (EEG)
Although EEG responses were altered at rest by COR, these
differences did not maintain significance during exercise. Due to
artifact the full complement of channels and subjects could not
be analyzed. The MC (n= 10) and VLPFC (n= 7) were analyzed
as previously described. Channel FP1 (n = 8) was analyzed in
representation of the ANTPFC and Fz (n = 7) was analyzed in
place of the DLPFC.
Data were calculated as percentage change from baseline and
analysis run with all five exercise time points and the final resting
time point (60) to give a reference point of change from resting
measures.
Prefrontal Cortex
Within all regions of the PFC, there was a significant effect of
time.
Anterior Prefrontal Cortex (FP1)
There was a significant effect of time in FP1 in αS, αF, β, and γ
(P < 0.05, P < 0.01, P < 0.001, P < 0.001, respectively). Post-hoc
analysis showed the differences across time to be from 60 min to
all exercise time points (P < 0.05).
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FIGURE 5 | BART test number of pumps (A) and number of adjusted pumps (B) in cortisol (COR), placebo (PLA), and baseline (BASE). The COR trial was
significantly higher than BASE in the total number of pumps made (A) (**P < 0.01) and the number of pumps made adjusted for the number of bursts (B) (*P < 0.05).
TABLE 2 | Performance data from each 30min trial.
Condition Distance Average power Average steady state Average sprint power Peak sprint power
covered (km) output (W) power output (W) output (W) output (W)
COR 17.45 ± 0.65 237.1 ± 27.43 227.1 ± 16.4 382.6 ± 65.72 461.4 ± 87.8*
PLA 17.52 ± 0.76 237.1 ± 20.64 225 ± 11.7 375 ± 75.73 499.8 ± 104.3
*Significantly lower (P < 0.05) than PLA.
Ventrolateral Prefrontal Cortex
There was a significant effect of time in VLPFC in αS, αF, β, and γ
(P < 0.05, P < 0.01, P < 0.001, P < 0.001, respectively). Post-hoc
analysis showed the differences across time to be from 60 min to
all exercise time points (P< 0.05) in all bandwidths except αS. In
αS there was a trend for a difference between exercise time points
1 and 3 (P = 0.09).
Dorsolateral Prefrontal Cortex (Fz)
There was a significant effect of time in Fz in αS, αF, β, and γ (P
< 0.001, P < 0.001, P < 0.001, P < 0.001, respectively). Post-hoc
analysis showed the differences across time to be from 60 min to
all exercise time points (P < 0.01) in all bandwidths.
Motor Cortex
There was a significant effect of time in MC in αS, αF, β, and γ (P
< 0.001, P < 0.001, P < 0.001, P < 0.001, respectively). Post-hoc
analysis showed the differences across time to be from 60 min to
all exercise time points (P < 0.001) in all bandwidths.
There was a significant decrease in β from exercise time point
2–5 (141.2 ± 11.8–131.2 ± 9.5; P <0.05) showing a decrease
during exercise toward the end.
Near-Infrared Spectroscopy (NIRS)
Steady State
During the steady state periods there was a significant decrease
from baseline in TOI in both COR and PLA trials (P < 0.05)
although in the COR trial TOI was lower to start with (Figure 7),
this was not significantly different to PLA. There was a significant
drug × time interaction in nTHI (P < 0.01) with COR higher on
average than PLA (8.78 ± 2.8 and 0.41 ± 8.2, respectively) but
post-hoc analysis revealed no significant differences between trials
(Figure 8A). OHb was significantly increased during exercise in
both COR and PLA (P < 0.001) reaching 3765 ± 2435 and 3458
± 1634% change by SS 5, respectively. While HHb increased in
COR (12787± 27418% change) and remained fairly level in PLA
(1603± 1724% change), these differences were not significant.
Sprints
Tissue oxygenation index (TOI) decreased over time in the COR
trial, being significantly lower at Spr 1 compared to 60min (−5.3
± 3.3 vs. 0.18 ±2.1) and a trend to be lower than 60min at
Spr 4 and 5 (−10.8 ± 8.2 and −13.9 ± 10.2, respectively; P <
0.05). Levels of TOI were lower in COR compared to PLA at
Spr 5 (−13.9 ± 10.2 vs. −6.5 ± 13.7, respectively; P < 0.05;
Figure 7B). There was also a decrease in the COR trial at Spr 1,
4, and 5 compared to PLA 60 (P < 0.05), whereas, there were no
changes across the PLA trial that reached significance. nTHI also
decreased across the COR trial, which whilst was not significant
reached a trend for significance at Spr 4 and 5 (P = 0.09 and
0.07; see Figure 8B). As with the SS, OHb was also significantly
increased from 60 to Spr 2–5 (P < 0.01) in both conditions with
a trend for an increase from 60 to Spr1 (P= 0.07). There were no
significant differences between conditions in HHb.
Salivary Cortisol Responses Post-exercise
Salivary cortisol values were significantly higher in COR than
PLA post-exercise (43.1 ± 14.8 vs. 16.3 ± 11.3 nmol/l,
respectively; P < 0.01). Post-exercise measures in COR were
higher than 0 (P < 0.05), 15 (P < 0.05), and 30 (P < 0.01). PLA
only increased over time at post-exercise with this time point
being significantly higher than all other time points (P < 0.01).
Salivary cortisol levels in the PLA trial post-exercise were also
significantly higher than COR 0 and 15 (0 and 15 min; P < 0.01).
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FIGURE 6 | Average power output (PO) during the COR (•) and PLA (o)
trials during the steady state (SS) periods (A) and the sprints (B). During
steady state PO decreased from SS2 to SS4 and SS5 (*P< 0.05).
DISCUSSION
Ingestion of exogenous cortisol significantly altered resting
measures of salivary cortisol and also EEG responses in both the
alpha slow and gamma bandwidths. These changes were related
to an increase in risk taking behavior as shown by the change in
the number of pumps made in the BART test whilst under the
influence of higher cortisol levels. During exercise, peak power
production was lower in the COR trial. Further differences during
the COR trial, compared to PLA, were identified in exercise
responses of TOI and nTHI during sprinting which were lower
than the PLA trial. There were no other differences in exercise
performance.
Changes in Salivary Cortisol Levels
Salivary cortisol levels were successfully elevated with the COR
condition over the 60 min rest following ingestion. Previous
studies using exogenous cortisol have found similar levels as these
(Buchanan and Lovallo, 2001; Henckens et al., 2012) although
higher levels have also been reported with similar protocols
(Putman et al., 2007, 2010). In the PLA trial salivary COR showed
a decline from initial baseline levels during rest. This has been
shown previously and likely reflects normal diurnal variation or
possibly habituation to the slight initial stress of coming into the
lab for a study (Putman et al., 2010). Despite the presence of
elevated cortisol levels prior to exercise, further cortisol release
was still stimulated from the adrenal cortex but there did not
seem to be a relationship between elevated cortisol levels and an
impact on exercise performance.
Risk Taking Behavior
The BART test provides a sequential assessment of risk
taking. There was one significant change in the number of
pumps made in the COR trial compared to the BASE. This
suggests that in the COR trial subjects made more pumps
in an attempt to win more money. However, there were no
changes between groups in terms of overall performance or
in pacing strategy that was suggestive of an altered perception
of risk. Previous research has shown that risk perception
can impact on initial pacing strategy (Micklewright et al.,
2015), however, we did not find that this was modulated
here.
In previous research showing motivated decision making
being increased by COR in some studies the participants
had much higher COR levels following a 40mg dose than
was shown in the present study; 116.4 nmol/l 1 h after
administration (Putman et al., 2010) vs. 29.7 ± 22.7 nmol/l
at 60 min post-administration and 33.8 ± 21.3 nmol/L
as peak values in the present study. This difference may
explain why we were not able to find more changes in
risk related behavior in our participants. Changes in risk
related behavior are also time dependent (Henckens et al.,
2012) and although we aimed to measure delayed effects
of exogenous cortisol, it is possible that some rapid effects
remained in some individuals and thus changes in reward based
decision making might have been impaired in this instance
(Koot et al., 2013). Further to this, HPA axis physiology
is determined by previous stressful events associated with
hypercortisolism (Herman and Cullinan, 1997; de Carvalho
Tofoli et al., 2011) and, therefore, it has been hypothesized
that endurance-trained individuals might develop adaptive
mechanisms such as decreased sensitivity to cortisol to
protect muscle and other glucocorticoid-sensitive tissues against
this increased post-exercise cortisol secretion (Duclos et al.,
2003).
Neurophysiological Measures
There were significant alterations to the neural responses at rest
in the EEG. Changes in neuronal excitability are known to occur
with glucocorticoid receptor mediated events (Joëls and de Kloet,
1992) such as would have occurred with exogenous cortisol. An
increase in alpha slow at rest in the COR trial, predominantly
within the PFC at the ANTPFC and VLPFC occurred, but
also in the MC. Our understanding of changes to alpha are
varied and, therefore, interpretation of these data is complex. For
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FIGURE 7 | Tissue oxygenation responses (TOI) in COR (•) and PLA (o) as % change from rest (60 min) to each steady state (SS) (A) and Sprint (Spr) (B)
interval. Main effect of drug (a) and time (b). Significant differences in COR from 60 to Spr 1 (**P < 0.01). Trend for COR Spr 4 and 5 (#P = 0.06 and 0.07 respectfully)
to be lower than COR 60. COR significantly lower than PLA 60 at Spr 1, 4, and 5 (&P < 0.05). Significant difference between COR and PLA at Spr 5 (δP < 0.05).
FIGURE 8 | Normalized tissue hemoglobin (nTHI) in COR (•) and PLA (o) as % change from rest (60 min) to each steady state (SS) (A) and Sprint (Spr) (B)
interval. Trend for COR Spr 4 and 5 (#P = 0.09 and 0.07 respectfully) to be lower than PLA.
example Alpha oscillations seen at the surface EEG occur when
there is disengagement of underlying cortical systems in active
processing (Coan and Allen, 2004) also described as inhibition
of neural ensembles (Uusberg et al., 2013). On the other hand it
is generally held that alpha oscillations are seen in surface EEG
if neurons are synchronously active across several centimeters
of cortex (Pfurtscheller and Lopes da Silva, 1999; Nunez et al.,
2001).
The presence of alpha has also been proposed to relate to
metabolism in the area in which it is measured. The increase in
alpha may, therefore, reflect a change in metabolism as a result
of the presence of the COR. Previous research has attempted
to examine the change in the blood oxygen level dependent
(BOLD) signal in conjunction with changes in frequency of alpha
bandwidth. Increased alpha activity has been shown to coincide
with decreases in blood flow to the same area (Oakes et al.,
2004) and to positively correlate with glucose metabolism and
activity in the thalamus (Schreckenberger et al., 2004) suggesting
a close functional relationship between thalamic activity and
alpha rhythm. These studies have predominantly examined
changes in the Occipital lobe created with eyes closed alpha
and, therefore, may make it difficult to apply these theories
to changes at the PFC which have been shown to relate to
attention and motivational affective responses (Uusberg et al.,
2013). However, desynchronization has also been found in both
frontal and parietal lobes to have greater BOLD signal, that is
greater metabolism with less alpha present (Laufs et al., 2003).
Changes in the EEG response at rest with exogenous COR
may, therefore, reflect a change in the areas of the brain that
are metabolically active which might be in conjunction with
increased activity of thalamic areas. The negative feedback role of
cortisol on the brain has been proposed to directly inhibit the core
structures of the HPA axis (Herman and Cullinan, 1997) which
would support a cause for changes in thalamic metabolism. If an
increase in alpha is reflective of inhibition or decoupling of neural
networks then thismay explain the EEG changes seen here, where
by the cortisol binds to GRs and suppresses subsequent HPA
activation. It may also be a reflection of changes in activity within
parts of the PFC involved in the HPA axis response and feedback
loop which might be expected (Crane et al., 2003; Joëls et al.,
2012).
During exercise the COR did have a significant impact
on cerebral oxygenation responses, predominantly during the
sprints where TOI signal declined over time throughout the
sprints. This continual decline in oxygenation during repeated
sprints is not uncommon (Racinais et al., 2007; Smith and Billaut,
2010; Smith et al., 2012) even though more mechanical work is
not produced to prompt a greater demand in brain circulation
or metabolism. The decline in nTHI would seem to indicate a
reduced blood volume in that area and in relation to the changes
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of TOI, the percentage of OHb within the blood flowing to that
region was less, suggesting a greater level of desaturation via
higher oxygen uptake (González-Alonso et al., 2004). This is
supported by the fact that HHb was higher in the COR trial,
although not significantly so. Higher HHb may indicate a greater
level of deoxygenation in the underlying tissue (Billaut et al.,
2010) which further suggests that the presence of COR created
a demand which lowered blood volume at the PFC and also
desaturated the PFC to a greater extent. However, these events
did not impact on exercise performance.
Oxygen availability did not change during the exercise period
as OHb remained elevated in both trials throughout exercise.
As power output was not affected by either condition this is
in support of previous findings that suggest maintenance of
oxygen availability does not impact on power output (Rooks
et al., 2010; Smith and Billaut, 2010). Although other changes
in NIRS measures may indicate a change in metabolism, oxygen
availability remained high which is in agreement with previous
findings that performance levels are maintained in this instance
(Rooks et al., 2010). These changes in NIRS are in support of
previous work showing that during self-paced exercise changes
in cerebral oxygenation remain within a range that does not
hinder exercise performance (Billaut et al., 2010) or conversely
that changes in these parameters are not an important indicator
for exercise regulation.
Decreased Peak Power Output
Despite decreases in peak power during exercise in the COR
trial, overall TT performance was not affected between the
two conditions. This, therefore, emphasizes the need to
examine several aspects of performance when manipulating
neurotransmitter responses. Previous manipulations of the
dopaminergic pathways during exercise have only shown
changes in time trial performance in the heat rather than
in normothermic environments (Watson et al., 2005;
Roelands et al., 2008). This may be due to the role of the
hypothalamus in the manipulation of these pathways and its
role in thermoregulation. In addition to this, previous research
interrupting the HPA axis prior to exercise with ACTH dose
has not shown any effects on maximal cycling performance
(Soetens et al., 1995). However, having found a change in
peak power output with elevated cortisol levels but no change
in overall exercise performance it may be prudent in future
research to include examination of several exercise models when
manipulating neurotransmitter responses.
LIMITATIONS
We would like to highlight the limitations to our study which
may impact on the interpretation of the results. We were unable
to provide monetary rewards to allow for payments to be made
at the end of the BART test. This means that essentially the
participants did not stand to lose anything, which may have
impacted on how they performed the test. The results may also
be limited in their interpretation due the relatively small n of 9.
CONCLUSION
In conclusion, ingestion of exogenous cortisol was
related to clear EEG changes at rest and NIRS changes
during exercise. These changes were in conjunction with
altered risk taking behavior as measured by the BART
test, but no change in overall exercise performance
occurred. Therefore, exogenous cortisol altered cognitive
behavioral responses to a risk task as has been previously
shown (Putman et al., 2010). Although peak power was
altered this was not sufficient to impact on overall TT
performance.
AUTHOR CONTRIBUTIONS
CR devised study design, carried out experimental measures,
undertook data analysis, interpretation, and writing of
manuscript. FM and MI assisted with study design, data
interpretation, and drafting and finalizing of manuscript.
FUNDING
Funding for this study was provided by a Charles Sturt University
Higher Degree by Research Scholarship.
REFERENCES
Aklin, W. M., Lejuez, C., Zvolensky, M. J., Kahler, C. W., and Gwadz, M. (2005).
Evaluation of behavioral measures of risk taking propensity with inner city
adolescents. Behav. Res. Ther. 43, 215–228. doi: 10.1016/j.brat.2003.12.007
Bailey, S. P., Hall, E. E., Folger, S. E., and Miller, P. C. (2008). Changes in EEG
during graded exercise on a recumbent cycle ergometer. J. Sports Sci. Med. 7,
505–511.
Billaut, F., Davis, J. M., Smith, K. J., Marino, F. E., and Noakes, T. D.
(2010). Cerebral oxygenation decreases but does not impair performance
during self-paced, strenuous exercise. Acta Physiol. 198, 477–486.
doi: 10.1111/j.1748-1716.2009.02058.x
Borg, G. (1990). Psychophysical scaling with applications in physical work
and the percetion of exertion. Scand. J. Work Environ. Health 16, 55–58.
doi: 10.5271/sjweh.1815
Brodmann, K. (2006). Localisation in the Cerebral Cortex: The Principles of
Comparative Localisation in the Cerebral Cortex Based on Cytoarchtectonics.
Boston, MA: Springer.
Buchanan, T. W., and Lovallo, W. R. (2001). Enhanced memory for
emotional material following stress-level cortisol treatment in humans.
Psychoneuroendocrinology 26, 307–317. doi: 10.1016/S0306-4530(00)00
058-5
Coan, J. A., and Allen, J. J. (2004). Frontal EEG asymmetry as
a moderator and mediator of emotion. Biol. Psychol. 67, 7–50.
doi: 10.1016/j.biopsycho.2004.03.002
Crane, J. W., Ebner, K., and Day, T. A. (2003). Medial prefrontal cortex
suppression of the hypothalamic-pituitary-adrenal axis response to a physical
stressor, systemic delivery of interleukin-1β. Eur. J. Neurosci. 17, 1473–1481.
doi: 10.1046/j.1460-9568.2003.02568.x
de Carvalho Tofoli, S. M., Von Werne Baes, C., Martins, C. M. S., and Juruena,
M. (2011). Early life stress, HPA axis, and depression. Psychol. Neurosci. 4, 229.
doi: 10.3922/j.psns.2011.2.008
de Koning, J. J., Foster, C., Bakkum, A., Kloppenburg, S., Thiel, C.,
Joseph, T., et al. (2011). Regulation of pacing strategy during athletic
competition. PLoS ONE 6:e15863. doi: 10.1371/journal.pone.00
15863
Frontiers in Physiology | www.frontiersin.org 12 December 2016 | Volume 7 | Article 640
Robertson et al. Exogenous Cortisol and Risk Taking Behavior
Duclos, M., Gouarne, C., and Bonnemaison, D. (2003). Acute and chronic effects
of exercise on tissue sensitivity to glucocorticoids. J. Appl. Physiol. 94, 869–875.
doi: 10.1152/japplphysiol.00108.2002
Follenius, M., Brandenberger, G., and Hietter, B. (1982). Diurnal cortisol peaks
and their relationships to meals. J. Clin. Endocrinol. Metab. 55, 757–761.
doi: 10.1210/jcem-55-4-757
González-Alonso, J., Dalsgaard, M. K., Osada, T., Volianitis, S., Dawson, E.
A., Yoshiga, C. C., et al. (2004). Brain and central haemodynamics and
oxygenation during maximal exercise in humans. J. Physiol. 557, 331–342.
doi: 10.1113/jphysiol.2004.060574
Hellhammer, D. H., Wüst, S., and Kudielka, B. M. (2009). Salivary cortisol
as a biomarker in stress research. Psychoneuroendocrinology 34, 163–171.
doi: 10.1016/j.psyneuen.2008.10.026
Henckens, M. J., van Wingen, G. A., Joëls, M., and Fernández, G. (2012).
Time-dependent effects of cortisol on selective attention and emotional
interference: a functional MRI study. Front. Integr. Neurosci. 6:66.
doi: 10.3389/fnint.2012.00066
Herman, J. P., and Cullinan, W. E. (1997). Neurocircuitry of stress: central control
of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20, 78–84.
doi: 10.1016/S0166-2236(96)10069-2
Joëls, M., and de Kloet, E. R. (1992). Control of neuronal excitability by
corticosteroid hormones. Trends Neurosci. 15, 25–30. doi: 10.1016/0166-2236
(92)90345-9
Joëls, M., Sarabdjitsingh, R. A., and Karst, H. (2012). Unraveling the time domains
of corticosteroid hormone influences on brain activity: rapid, slow, and chronic
modes. Pharmacol. Rev. 64, 901–938. doi: 10.1124/pr.112.005892
Koob, G. F., and Bloom, F. E. (1988). Cellular and molecular mechanisms of drug
dependence. Science 242, 715–726. doi: 10.1126/science.2903550
Koot, S., Baars, A., Hesseling, P., van den Bos, R., and Joëls, M. (2013). Time-
dependent effects of corticosterone on reward-based decision-making in a
rodent model of the Iowa Gambling Task. Neuropharmacology 70, 306–315.
doi: 10.1016/j.neuropharm.2013.02.008
Laufs, H., Kleinschmidt, A., Beyerle, A., Eger, E., Salek-Haddadi, A., Preibisch, C.,
et al. (2003). EEG-correlated fMRI of human alpha activity. NeuroImage 19,
1463–1476. doi: 10.1016/S1053-8119(03)00286-6
Lejuez, C. W., Read, J. P., Kahler, C. W., Richards, J. B., Ramsey, S. E., Stuart,
G. L., et al. (2002). Evaluation of a behavioral measure of risk taking:
the Balloon Analogue Risk Task (BART). J. Exp. Psychol. Appl. 8, 75–84.
doi: 10.1037/1076-898x.8.2.75
Lejuez, C., Aklin, W. M., Jones, H. A., Richards, J. B., Strong, D. R., Kahler, C. W.,
et al. (2003a). The balloon analogue risk task (BART) differentiates smokers and
nonsmokers. Exp. Clin. Psychopharmacol. 11, 26–33. doi: 10.1037/1064-1297.
11.1.26
Lejuez, C., Aklin, W. M., Zvolensky, M. J., and Pedulla, C. M. (2003b). Evaluation
of the Balloon Analogue Risk Task (BART) as a predictor of adolescent real-
world risk-taking behaviours. J. Adolesc. 26, 475–479. doi: 10.1016/S0140-
1971(03)00036-8
Lejuez, C., Simmons, B. L., Aklin, W. M., Daughters, S. B., and Dvir, S. (2004).
Risk-taking propensity and risky sexual behavior of individuals in residential
substance use treatment. Addict. Behav. 29, 1643–1647. doi: 10.1016/j.addbeh.
2004.02.035
Marinelli, M., Aouizerate, B., Barrot, M., Le Moal, M., and Piazza, P.
V. (1998). Dopamine-dependent responses to morphine depend on
glucocorticoid receptors. Proc. Natl. Acad. Sci. U.S.A. 95, 7742–7747.
doi: 10.1073/pnas.95.13.7742
Marinelli, M., and Piazza, P. V. (2002). Interaction between glucocorticoid
hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 16, 387–394.
doi: 10.1046/j.1460-9568.2002.02089.x
Micklewright, D., Parry, D., Robinson, T., Deacon, G., Renfree, A., St. Clair Gibson,
A., et al. (2015). Risk perception influences athletic pacing strategy. Med. Sci.
Sports Exerc. 47, 1026–1037. doi: 10.1249/MSS.0000000000000500
Mikics, É., Barsy, B., and Haller, J. (2007). The effect glucocorticoids on
aggressiveness in established colonies of rats. Psychoneuroendocrinology 32,
160–170. doi: 10.1016/j.psyneuen.2006.12.002
Nielsen, B., Hyldig, T., Bidstrup, F., González-Alonso, J., and Christoffersen,
G. R. (2001). Brain activity and fatigue during prolonged exercise in
the heat. Pflugers Arch. Eur. J. Physiol. 442, 41–48. doi: 10.1007/s004240
100515
Nunez, P. L., Wingeier, B. M., and Silberstein, R. B. (2001). Spatial-temporal
structures of human alpha rhythms: theory, microcurrent sources, multiscale
measurements, and global binding of local networks. Hum. Brain Mapp. 13,
125–164. doi: 10.1002/hbm.1030
Oakes, T. R., Pizzagalli, D. A., Hendrick, A. M., Horras, K. A., Larson, C. L.,
Abercrombie, H. C., et al. (2004). Functional coupling of simultaneous electrical
and metabolic activity in the human brain. Hum. Brain Mapp. 21, 257–270.
doi: 10.1002/hbm.20004
Okada, E., Firbank, M., and Delpy, D. T. (1995). The effect of overlying tissue on
the spatial sensitivity profile of near-infrared spectroscopy. Phys. Med. Biol. 40,
2093. doi: 10.1088/0031-9155/40/12/007
Pfurtscheller, G., and Lopes da Silva, F. H. (1999). Event-related EEG/MEG
synchronization and desynchronization: basic principles. Clin. Neurophysiol.
110, 1842–1857. doi: 10.1016/S1388-2457(99)00141-8
Piazza, P. V., Barrot, M., Rougé-Pont, F., Marinelli, M., Maccari, S., Abrous, D. N.,
et al. (1996a). Suppression of glucocorticoid secretion and antipsychotic drugs
have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl.
Acad. Sci. U.S.A. 93, 15445–15450. doi: 10.1073/pnas.93.26.15445
Piazza, P. V., Maccari, S., Deminière, J.-M., Le Moal, M., Mormède, P., and
Simon, H. (1991). Corticosterone levels determine individual vulnerability to
amphetamine self-administration. Proc. Natl. Acad. Sci. U.S.A. 88, 2088–2092.
doi: 10.1073/pnas.88.6.2088
Piazza, P. V., Rougé-Pont, F., Deroche, V., Maccari, S., Simon, H., and Le Moal,
M. (1996b). Glucocorticoids have state dependent stimulant effects on the
mesencephalic dopaminergic transmission. Proc. Natl. Acad. Sci. U.S.A. 93,
8716–8720. doi: 10.1073/pnas.93.16.8716
Putman, P., Antypa, N., Crysovergi, P., and van der Does, W. A. (2010).
Exogenous cortisol acutely influences motivated decision making in healthy
young men. Psychopharmacology 208, 257–263. doi: 10.1007/s00213-009-1
725-y
Putman, P., Hermans, E. J., Koppeschaar, H., van Schijndel, A., and van Honk,
J. (2007). A single administration of cortisol acutely reduces preconscious
attention for fear in anxious young men. Psychoneuroendocrinology 32,
793–802. doi: 10.1016/j.psyneuen.2007.05.009
Racinais, S., Bishop, D., Denis, R., Lattier, G., Mendez-Villaneuva, A.,
and Perrey, S. (2007). Muscle deoxygenation and neural drive to the
muscle during repeated sprint cycling. Med. Sci. Sports Exerc. 39, 268.
doi: 10.1249/01.mss.0000251775.46460.cb
Renfree, A., Martin, L., Micklewright, D., and St. Clair Gibson, A. (2014).
Application of decision-making theory to the regulation of muscular work
rate during self-paced competitive endurance activity. Sports Med. 44, 147–158.
doi: 10.1007/s40279-013-0107-0
Renfree, A., West, J., Corbett, M., Rhoden, C., and St. Clair Gibson, A.
(2012). Complex interplay between determinants of pacing and performance
during 20 km cycle time trials. Int. J. Sports Physiol. Perform. 7, 121–129.
doi: 10.1123/ijspp.7.2.121
Robertson, C. V., and Marino, F. E. (2015). Prefrontal and motor cortex
EEG responses and their relationship to ventilatory thresholds during
exhaustive incremental exercise. Eur. J. Appl. Physiol. 115, 1939–1948.
doi: 10.1007/s00421-015-3177-x
Roelands, B., Goekint, M., Heyman, E. M., Piacentini, M. F., Watson, P.,
Hasegawa, H., et al. (2008). Acute norepinephrine reuptake inhibition decreases
performance in normal and high ambient temperature. J. Appl. Physiol. 105,
206–212. doi: 10.1152/japplphysiol.90509.2008
Roitman, M. F., Wheeler, R. A., and Carelli, R. M. (2005). Nucleus accumbens
neurons are innately tuned for rewarding and aversive taste stimuli, encode
their predictors, and are linked to motor output. Neuron 45, 587–597.
doi: 10.1016/j.neuron.2004.12.055
Rooks, C. R., Thom, N. J., McCully, K. K., and Dishman, R. K. (2010).
Effects of incremental exercise on cerebral oxygenation measured by near-
infrared spectroscopy: a systematic review. Prog. Neurobiol. 92, 134–150.
doi: 10.1016/j.pneurobio.2010.06.002
Rougé-Pont, F., Deroche, V., Le Moal, M., and Piazza, P. V. (1998).
Individual differences in stress-induced dopamine release in the nucleus
accumbens are influenced by corticosterone. Eur. J. Neurosci. 10, 3903–3907.
doi: 10.1046/j.1460-9568.1998.00438.x
Rowan, J. A., and Tolunsky, E. (2006). Origin and Technical Aspects of the EEG
Primer of EEG. Philadelphia, PA: Elsevier, 1–21.
Frontiers in Physiology | www.frontiersin.org 13 December 2016 | Volume 7 | Article 640
Robertson et al. Exogenous Cortisol and Risk Taking Behavior
Schreckenberger, M., Lange-Asschenfeld, C., Lochmann, M., Mann, K., Siessmeier,
T., Buchholz, H.-G., et al. (2004). The thalamus as the generator and modulator
of EEG alpha rhythm: a combined PET/EEG study with lorazepam challenge in
humans. Neuroimage 22, 637–644. doi: 10.1016/j.neuroimage.2004.01.047
Smith, K. J., and Billaut, F. (2010). Influence of cerebral and muscle
oxygenation on repeated-sprint ability. Eur. J. Appl. Physiol. 109, 989–999.
doi: 10.1007/s00421-010-1444-4
Smith, K. J., Billaut, F., Argus, C. K., Gill, N. D., Keogh, J. W., McGuigan, M. R.,
et al. (2012). Tissue oxygenation in men and women during repeated-sprint
exercise. Int. J. Sports Physiol. Perform. 7, 59–67. doi: 10.1123/ijspp.7.1.59
Soetens, E., Hueting, J., and De Meirleir, K. (1995). No influence of ACTH on
maximal performance. Psychopharmacology 118, 260–266. doi: 10.1007/BF02
245953
Uusberg, A., Uibo, H., Kreegipuu, K., and Allik, J. (2013). EEG alpha and
cortical inhibition in affective attention. Int. J. Psychophysiol. 89, 26–36.
doi: 10.1016/j.ijpsycho.2013.04.020
Van Beekvelt, M. C. P., Colier, W. N. J. M., Wevers, R. A., and Van Engelen, B. G.
M. (2001). Performance of near-infrared spectroscopy in measuring local O2
consumption and blood flow in skeletal muscle. J. Appl. Physiol. 90, 511–519.
Van der Zee, P., Cope, M., Arridge, S., Essenpreis, M., Potter, L., Edwards, A., et al.
(1992). Experimentally Measured Optical Pathlengths for the Adult Head, Calf
and Forearm and the Head of the Newborn Infant As a Function of Inter Optode
Spacing. Oxygen Transport to Tissue XIII. Boston, MA: Springer, 143–153.
van Peer, J. M., Roelofs, K., and Spinhoven, P. (2008). Cortisol administration
enhances the coupling of midfrontal delta and beta oscillations.
Int. J. Psychophysiol. 67, 144–150. doi: 10.1016/j.ijpsycho.2007.
11.001
Watson, P., Hasegawa, H., Roelands, B., Piacentini, M. F., Looverie, R., and
Meeusen, R. (2005). Acute dopamine/noradrenaline reuptake inhibition
enhances human exercise performance in warm, but not temperate conditions.
J. Physiol. 565, 873–883. doi: 10.1113/jphysiol.2004.079202
Williams, E. L., Jones, H. S., Andy Sparks, S., Marchant, D. C., Midgley, A. W., and
McNaughton, L. R. (2015). Competitor presence reduces internal attentional
focus and improves 16.1 km cycling time trial performance. J. Sci. Med. Sport
18, 486–491. doi: 10.1016/j.jsams.2014.07.003
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Robertson, Immink and Marino. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 14 December 2016 | Volume 7 | Article 640
